Internal Server Error

Peak Proteins - About the company

Peak Proteins is an acquired company based in Alderley Edge (United Kingdom), founded in 2015 by Mark Abbott. It operates as a Provider of service for proteomics and structural biology. Peak Proteins has raised an undisclosed amount in funding. The company has 33 active competitors, including 2 funded and 3 that have exited. Its top competitors include companies like Nabla, Proteros and Beryllium.

Company Details

Peak proteins is a service provider in protein purification, expression, characterization, and production. They use E.coli (T7 promoter), baculovirus/insect cells and mammalian cells to express and purify the protein. For baculovirus/insect cells system the technology they use is flashBACTM technology from Oxford Expression Technologies. FlashBACTM involves co-transfection of two plasmids in the culture to produce a virus, and for mammalian cells they use, the most popular HEK293cells. Additionally, it also provides structure determination services for proteins, wherein along with the detailed analysis of the structure, they also suggest drug designs.
Email ID
*****@peakproteins.com
Phone Number
+44 **********
Key Metrics
Founded Year
2015
Location
Alderley Edge, United Kingdom
Stage
Acquired
Ranked
Employee Count
34 as on Jun 30, 2026
Similar Companies
Exit Details
Acquired by Sygnature Discovery (Apr 01, 2022)

Peak Proteins's acquisition details

Peak Proteins got acquired by Sygnature Discovery on Apr 01, 2022.
Click here to take a look at Peak Proteins's acquisition in detail
Sign up to download Peak Proteins' company profile

Peak Proteins's funding and investors

Peak Proteins has raised funding over 2 rounds. Its first funding round was on Jan 27, 2016. Its latest funding round was a Grant (prize money) round on Sep 01, 2020 for $*****. 1 investor participated in its latest round. Peak Proteins has 3 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Peak Proteins:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 01, 2020
7822900
Grant (prize money)
3696382
9108457
4045946
6540180
Jan 27, 2016
4985009
Seed
6567527
1950392
9670394
lockAccess funding benchmarks and valuations. Sign up today!

Peak Proteins' founders and board of directors

Founder? Claim Profile
The founders of Peak Proteins is Mark Abbott.
Here are the details of Peak Proteins' key team members:

Peak Proteins' employee count trend

Peak Proteins has 34 employees as of Jun 26. Here is Peak Proteins's employee count trend over the years:
Employee count trend for Peak Proteins
lockUncover Peak Proteins' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Peak Proteins's Competitors and alternates

Top competitors of Peak Proteins include Nabla, Proteros and Beryllium. Here is the list of Top 10 competitors of Peak Proteins, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Nabla
Nabla
2020, Boston (United States), Series A
Provider of synthetic biology platform to identify functional proteins
$37M
60/100
2nd
Logo for Proteros
Proteros
1999, Germany, Early Stage
Provider of structure-based early-stage drug discovery services and technology platform
$13.2M
46/100
3rd
Logo for Beryllium
Beryllium
1999, Bedford (United Kingdom), Acquired
Boutique service provider offering a range of solutions for drug discovery
$11.5M
41/100
4th
Logo for ChemPartner
ChemPartner
2002, Shanghai (China), Unfunded
CRO offering services to the pharma and biotech industries
-
-
39/100
5th
Logo for Creative Biostructure
Creative Biostructure
2001, New York City (United States), Unfunded
Provider of structural biology and membrane protein services for pharma industries
-
-
38/100
6th
Logo for Peak Proteins
Peak Proteins
2015, Alderley Edge (United Kingdom), Acquired
Provider of service for proteomics and structural biology
-
37/100
7th
Logo for Athebio
Athebio
2019, Schlieren (Switzerland), Unfunded
Provider of binding molecules based on repeat proteins to aid drug discovery
-
-
33/100
8th
Logo for Fina Biosolutions
Fina Biosolutions
2006, Rockville (United States), Seed
Conjugate vaccine solutions, bioconjugation services, and functionalized dextrans for emerging markets
$3M
31/100
9th
Logo for Crelux
Crelux
2005, Planegg (Germany), Acquired
X-ray crystallography, fragment based drug discovery and protein delivery.
-
31/100
10th
Logo for BioSuperior Technology
BioSuperior Technology
2014, Los Altos (United States), Funding Raised
Early stage drug discovery services
-
27/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Peak Proteins's competitors? Click here to see the top ones

Peak Proteins's Investments and acquisitions

Peak Proteins has made no investments or acquisitions yet.

Reports related to Peak Proteins

Here is the latest report on Peak Proteins's sector:

News related to Peak Proteins

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Peak Proteins

Explore our recently published companies
  • InterviewGod - Bengaluru based, 2023 founded, Unfunded company
  • InPager - Monterrey based, 2022 founded, Funding Raised company
  • Nurse Yard - Clearwater based, 2020 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford